Medtronic plc (NYSE:MDT) ranks among the best medical device stocks to invest in. Following a tour of the company’s HUGO soft ...

The Hugo Surgical Robot from Medtronic is a new system for robot-assisted surgery, aiming to make procedures less invasive.

The study aims to validate an integrated surgical ecosystem that combines robotics, imaging, instrumentation and workflow optimisation ...

Medtronic (MDT) just announced the launch of a new clinical study in the U.S. that will test its Hugo robotic-assisted ...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their progress in this roundup of the latest developments in surgical robotics.

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting Primary safety and effectiveness ...

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Hugo is already on the market in some countries, but made a slow start commercially. Medtronic cut its sales forecast in 2021, slashing the midpoint of its range from $75 million to $30 million. Sales ...

Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to evaluate the safety and effectiveness of its Hugo™ ...

Medtronic (NYSE:MDT) shares ticked up after the company met key effectiveness and safety goals in a study evaluating its Hugo robotic-assisted surgery system for inguinal and ventral hernia repairs.

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top five robotic surgeons in the U.S. James Porter serves as medical director of ...